Get the tools used by (smart)2 investors.

Cash from Operations for Nevro Corp

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

NVRO: Nevro Corp

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stim...

5.84 USD
Price
USD
Fair Value
Upside
3.17 - 14.70
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Nevro Corp's Cash from Operations:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 2024-100 M-60 M-20 M20 M

Performance Summary
  • Nevro's latest twelve months cash from operations is -19.439 million
  • Nevro's cash from operations for fiscal years ending December 2020 to 2024 averaged -18.857 million.
  • Nevro's operated at median cash from operations of -19.439 million from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Nevro's cash from operations peaked in December 2022 at 24.675 million.
  • Nevro's cash from operations hit its 5-year low in December 2023 of -58.829 million.
  • Nevro's cash from operations decreased in 2021 (-41.881 million, -3,616.5%) and 2023 (-58.829 million, -338.4%) and increased in 2020 (1.191 million, -102.4%), 2022 (24.675 million, -158.9%), and 2024 (-19.439 million, -67.0%).

How does Nevro Corp's Cash from Operations benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Nevro Corp because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Cash from Operations

Hide this widget
cash_from_operations
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Cash from Operations in the financials category include:

View Full List

Search for metric or datapoint

Cash from Operations

Represents the amount of cash generated or consumed by a company's core business operations

Definition of Cash from Operations

Hide this widget

_invpro_glossary_calculation_undefined_year

The tables below summarizes Nevro’s Cash from Operations and common size over the last five years:

Fiscal YearCash from Operations
2020-12-311.191 M
2021-12-31-41.881 M
2022-12-3124.675 M
2023-12-31-58.829 M
2024-12-31-19.439 M

The tables below summarizes Nevro’s Cash from Operations and common size over the last four quarters:

Quarter EndingCash from Operations
2024-03-31-32.656 M
2024-06-30-8.11 M
2024-09-302.732 M
2024-12-3118.595 M

Click the link below to download a spreadsheet with an example Cash from Operations calculation for Nevro Corp below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-61.273 M-31.273 M-1.273 M43.109 M0200400

The chart above depicts the distribution of cash from operations for companies operating in the Healthcare sector in the Developed economic region. Over 3,175 companies were considered in this analysis, and 1,947 had meaningful values. The average cash from operations of companies in the sector is -8.12 M with a standard deviation of 17.335 M.

Nevro Corp's Cash from Operations of -19.439 M ranks in the 21.2% percentile for the sector. The following table provides additional summary stats:

Cash from Operations In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents3,180
Included Constituents1,947
Min-58.788 M
Max40.624 M
Median-3.522 M
Mean-8.12 M
Standard Deviation17.335 M

You can find companies with similar cash from operations using this stock screener.

All rights reserved. Terms Of Use